11.08.2011 • News

China Pharma Holdings Q2 Profit Down

China Pharma Holdings reported that its second-quarter net income was $5.1 million, or $0.12 per share, down from $6.1 million, or $0.14 per share, in the second quarter of 2010. Excluding the effect of change in fair value of derivative warrant liability, adjusted non-GAAP net income in the second quarter of 2011 was $4.8 million, or $0.11 per share, compared to $5.3 million, or $0.12 per share, in the second quarter of 2010.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.